In vitro models for studying toxicity of antifungal agents.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Fluconazole penetration in cerebral parenchyma in humans at steady state.Antimicrobial agents and chemotherapy · 1995
   Trial
2. Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study.Annals of dermatology · 2016
   Article
3. Potential Use of Phenolic Acids as Anti-Candida Agents: A Review.Frontiers in microbiology · 2015
   Review
4. Virulence of a phosphoribosylaminoimidazole carboxylase-deficient Candida albicans strain in an immunosuppressed murine model of systemic candidiasis.Infection and immunity · 2001
   Article
5. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.Antimicrobial agents and chemotherapy · 2000
   Article
6. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species.Antimicrobial agents and chemotherapy · 1997
   Article
7. Diversity of lipid-based polyene formulations and their behavior in biological systems.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1997
   Review
8. Carrier effects on biological activity of amphotericin B.Clinical microbiology reviews · 1996
   Review
9. Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.Antimicrobial agents and chemotherapy · 1994
   Article
10. mSphere
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as